Clinical Trial Update: Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating glatiramer acetate in clinically isolated syndrome or early relapsing-remitting multiple sclerosis; uses optical coherence tom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Amphia Hospital | Conditions: Multiple Sclerosis | Phase 4 | Status: UNKNOWN